Medical Technology - Cyprus

Cyprus

In 2024, the revenue in the Medical Technology market market in Cyprus is estimated to reach US$129.50m.
Among the various markets in this market, Medical Devices is the largest, with a projected market volume of US$109.10m in the same year.
Looking ahead, the revenue is expected to exhibit an annual growth rate (CAGR 2024-2028) of 5.82%, resulting in a market volume of US$162.40m by 2028.
It is worth noting that in a global context, the United States is anticipated to generate the highest revenue, reaching US$215.80bn in 2024.
Cyprus is rapidly embracing medical technology advancements, paving the way for innovative solutions and improved healthcare outcomes.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in Cyprus is experiencing significant growth and development in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trend. Customer preferences in the Medical Technology market in Cyprus are driving the growth and development of the industry. Customers are increasingly seeking advanced medical technologies and innovative solutions to improve healthcare outcomes. They are willing to invest in state-of-the-art medical devices and equipment that can provide accurate diagnoses, effective treatments, and better patient care. Additionally, customers are also demanding more personalized and patient-centric healthcare solutions, which is driving the development of new medical technologies in Cyprus. Trends in the market are also playing a crucial role in the growth of the Medical Technology sector in Cyprus. One significant trend is the increasing adoption of digital health technologies. The integration of digital health solutions, such as telemedicine, electronic health records, and remote patient monitoring, is revolutionizing the healthcare system in Cyprus. These technologies enable healthcare providers to deliver care more efficiently, improve patient access to healthcare services, and enhance the overall quality of care. The demand for digital health technologies is expected to continue to rise, driving further growth in the Medical Technology market. Another trend in the market is the focus on research and development. Cyprus has been investing heavily in research and development in the healthcare sector, leading to the development of cutting-edge medical technologies. The government and private sector are collaborating to promote innovation and entrepreneurship in the Medical Technology industry. This focus on research and development is attracting both local and international investors, further fueling the growth of the market. Local special circumstances also contribute to the development of the Medical Technology market in Cyprus. The country's strategic location at the crossroads of Europe, Asia, and Africa makes it an ideal hub for medical technology companies to access multiple markets. Cyprus also has a well-developed healthcare infrastructure and a highly skilled workforce, which attracts foreign companies to establish their presence in the country. Additionally, the government of Cyprus has implemented policies and incentives to promote the growth of the Medical Technology sector, such as tax benefits and grants for research and development activities. Underlying macroeconomic factors, such as population demographics and healthcare expenditure, are also driving the growth of the Medical Technology market in Cyprus. The aging population and the increasing prevalence of chronic diseases create a growing demand for medical technologies and healthcare services. Furthermore, the government's commitment to increasing healthcare expenditure and improving healthcare infrastructure further supports the growth of the Medical Technology sector. In conclusion, the Medical Technology market in Cyprus is experiencing significant growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for advanced medical technologies, the adoption of digital health solutions, the focus on research and development, the strategic location of Cyprus, and the government's support are all contributing to the positive trend in the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.